Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1171 studies found for:    "Parasitic Diseases"
Show Display Options
Rank Status Study
1 Recruiting Parasitic Infections of the Gastrointestinal Tract
Conditions: Amebiasis;   Cryptosporidiosis;   Giardiasis;   Parasitic Disease;   Parasitic Intestinal Disease;   Gastrointestinal Helminth Infections
Intervention:
2 Completed Safety and PK Study of Ha44 Gel Under Maximal Use Conditions for Treatment of Head Lice Infestation
Condition: Head Lice Infestation
Intervention: Drug: Ha44 Gel
3 Recruiting Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection
Condition: Parasitic Disease
Intervention:
4 Recruiting Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Condition: Head Lice Infestation
Interventions: Drug: Abametapir Lotion 0.74% w/w;   Drug: Vehicle Lotion
5 Active, not recruiting Phase 3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
Condition: Head Lice Infestation
Intervention: Drug: Abametapir Lotion 0.74% w/w
6 Active, not recruiting P3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation
Condition: Head Lice Infestation
Intervention: Drug: Abametapir Lotion 0.74% w/w
7 Completed Impact of Hand Hygiene Activities on the Prevention of Intestinal Parasitic Infections and Anaemia Among School Children
Conditions: Intestinal Parasitic Infections;   Anaemia
Intervention: Behavioral: Hand washing with soap and hand finger nail clipping
8 Active, not recruiting A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation
Condition: Head Lice Infestation
Intervention: Drug: Ha44 Gel 0.74% w/w
9 Completed Ivermectin in the Treatment of Head Lice
Condition: Lice Infestations
Interventions: Drug: ivermectin;   Drug: malathion
10 Recruiting Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
Conditions: Asthma;   Eosinophilia;   Helminthiasis;   Hypersensitivity;   Parasitic Disease
Intervention:
11 Completed
Has Results
A Study Evaluating the Safety and Efficacy of BGC20-0582 Lice Treatment Gel for Head Lice Infestation
Conditions: Pediculus Humanus Capitis;   Head Lice
Interventions: Drug: Placebo;   Drug: BGC20-0582
12 Terminated Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice
Condition: Lice Infestations
Intervention: Drug: MALG
13 Completed Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice
Condition: Lice Infestations
Interventions: Drug: MALG;   Drug: Ovide (malathion) lotion 0.05%;   Drug: Permethrin 1%
14 Completed
Has Results
Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice
Condition: Pediculus Capitis Infestation
Interventions: Drug: Spinosad;   Drug: Permethrin 1%
15 Completed The Sero-Prevalence and Genetic Study for the Infectious Diseases and Metabolic Syndrome in Solomon Islands
Conditions: Flavivirus Infection;   Alphavirus Infections;   Malaria;   Parasitic Disease;   Leptospirosis;   Hypertension;   Metabolic Syndromes
Intervention: Other: diagnosis, treatment and education
16 Available Compassionate Use of Triclabendazole for the Treatment of Parasites (Prior to FDA Approval; Expanded Access Program)
Condition: Parasitic Disease
Intervention: Drug: Triclabendazole
17 Unknown  Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158
Conditions: Trypanosomiasis;   Trypanosomiasis, African;   Protozoan Infections;   Parasitic Diseases
Interventions: Drug: SCYX-7158;   Drug: Placebo
18 Completed Safety and Efficacy of Drug Combinations Against Schistosomiasis
Condition: Parasitic Diseases
Interventions: Drug: albendazole + praziquantel;   Drug: mebendazole + praziquantel
19 Completed Safety and Efficacy of Drug Combinations Against Triple Infections
Condition: Parasitic Diseases
Interventions: Drug: albendazole + ivermectin + praziquantel;   Drug: albendazole + ivermectin + (1 week later) praziquantel
20 Completed Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome;   Disease Progression;   Immune System Diseases;   Malaria;   Parasitic Diseases;   Pneumonia;   Diarrhea;   Infectious Disorder of Immune System
Intervention: Other: Discontinue TMP/SMZ prophylaxis

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years